Full-Time

Trauma Sales Representative

Posted on 11/5/2025

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

No salary listed

Company Historically Provides H1B Sponsorship

Salt Lake City, UT, USA

In Person

On-call nights/weekends/holidays required; field-based with ~80% travel. Local to Salt Lake City.

Category
Sales & Account Management (1)
Required Skills
Sales
Customer Service
Requirements
  • On-call schedule including nights, weekends, and holidays.
  • Integrity: Reliable, dependable, trustworthy, honest, and ethical.
  • Initiative: Willing to take on new responsibilities and challenges, and jump in without prompting.
  • Engaged in active learning: Understand the implications of new information for both current and future problem-solving and decision-making and interested in continuing to build your knowledge base through formal training and experience-based learning opportunities.
  • Service orientation, customer service, and satisfaction: Actively look for ways to help people. Familiarity with handling customer expectations in a professional manner and anticipating and addressing their needs and desires. Provide flexible customer service to ensure customer satisfaction and fidelity to Stryker’s products and services.
  • Relationship management: Build lasting and meaningful trust-based relationships with customers by providing timely, accurate, and sound advice to ensure satisfaction.
  • Social perceptiveness: Awareness of others' reactions and understanding why they react as they do (i.e. you are good at ‘reading a room’ and engaging appropriately).
  • Problem solving: Identify complex problems and review related information to develop and evaluate options and implement solutions, particularly when it comes to managing client cases and competing priorities.
  • Attention to detail: Thoroughness in accomplishing a task through concern for all aspects involved, no matter how small.
  • Following directions: Carry out the details of a task as directed.
  • Time management: Manage one's own time and the time of others to meet deadlines, particularly when there are competing priorities.
  • Prioritize tasks: Organize tasks according to their importance and urgency.
  • Flexible schedule for meeting outside regular hours: Work non-traditional hours and be on call most nights and weekends on short notice. This is a lifestyle job! Folks that thrive in the role really embrace the variety in the role and irregular hours that go with it.
  • Comfort in operating and emergency rooms: Comfort working in operating and emergency room settings and other high pressure, fast-paced environments.
  • Ability to monitor processes, materials, and surroundings: Monitor and review information from materials, events, and the environment, to detect or assess problems, particularly in operating room and other medical settings.
  • Provide consultation and advice: Provide guidance and expert advice to management or other groups on technical systems and process related topics.
  • Technical communication: Ability to explain the technical details of Stryker’s products and services to non-technical customers, stakeholders, or any other interested parties in a clear and concise manner.
  • Demonstrate motivation for sales: Show drive to reach sales goals and business targets.
  • Basic computer literacy: Proper use of email, Microsoft Office, and any relevant software applications/platforms.
  • Reading comprehension and written communication: Read and comprehend work-related documents, particularly medical product specifications and training materials. Communicate effectively as appropriate for the needs of internal and external audiences.
Responsibilities
  • Support sales of Stryker Trauma products that meet customers’ most pressing needs under the supportive supervision of a Trauma Sales Representative.
  • Receive best-in-class formal training on the Trauma product portfolio and sales methodology, including on-the-job training in the operating room.
  • Become an expert on surgical procedures by observing well over 300 medical procedures in the first year.
  • Develop a high level of competency in orthopedic surgical needs and procedures and become a valuable member of the surgical team who positively impacts surgical outcomes.
  • Be comfortable being on call most nights and weekends.
  • Become a trusted partner to clients through focus on client service, excellent account management, and commitment to improving healthcare.

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Simplify Jobs

Simplify's Take

What believers are saying

  • Robotic surgery leadership drives double-digit sales growth through 2025.
  • India Trident II launch targets aging population's rising hip surgeries.
  • Peripheral vascular expansion via IVL meets growing arterial disease demand.

What critics are saying

  • Handala cyberattack on March 11 delays ortho supply chain 3-6 months.
  • Zimmer Biomet Persona IQ erodes ortho share with real-time analytics.
  • J&J Velys captures 25% more knee procedures from Mako in 6-12 months.

What makes Stryker unique

  • Stryker holds 39.1% US market share in orthopedic product manufacturing.
  • Trident II Acetabular System integrates Mako SmartRobotics for hip replacements.
  • Amplitude Vascular Systems acquisition adds CO₂ IVL for peripheral arteries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Company News

ASC News
Apr 13th, 2026
ASC Technology Roundup: Distalmotion Files for Expanded Robotic Gynecology Clearance; Stryker, Medtronic Make Acquisitions

Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…

Market Wire News
Apr 13th, 2026
Stryker to acquire Amplitude Vascular Systems, adding next-gen IVL tech to peripheral vascular portfolio

Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.

Yahoo Finance
Mar 18th, 2026
Stryker posts 11% Q4 growth amid tariff pressures, margin expansion continues

Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.

Yahoo Finance
Mar 13th, 2026
Stryker shares fall 9% to $339 after Iranian cyberattack wipes 200,000+ systems

Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.

Yahoo Finance
Mar 12th, 2026
Stryker reports 11.4% revenue growth in Q4, beating estimates with $7.17B

Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.

INACTIVE